Stem Cells As Target for Prostate Cancer Therapy: Opportunities and Challenges

Scientists explore the relevance of evaluating the TLR3 and P53 status in prostate cancer patients before starting an immunotherapy based on the use of Polyinosinic:Polycytidylic acid +9cRA to determine whether they will be responsive to treatment.